ELV · Elevance Health, Inc. · Documents
$439.95
-5.33 (-1.20%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$95.05B
Shares
216.06M
Volume · Oct 23
1.17M
Avg daily vol (3M)
1.15M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | Elevance Health reported third-quarter 2026 operating revenue of $50.4 billion, up 0.7%, and diluted EPS of $6.27. It raised FY 2026 diluted EPS guidance to at least $22.00 and adjusted diluted EPS guidance to at least $29.00. | 2026-10-21 | — | |
| 10-Q | Elevance Health reported shareholders’ net income of $1,365 for the three months ended September 30, 2026, up 14.8%, while nine-month net income fell 10.2% to $4,592; medical membership declined 1.1% to 44,882 thousand. | 2026-10-21 | 2026-09-30 | |
| Investor Event Transcript | — | 2026-09-10 | 2026-09-30 | |
| 8-K | — | 2026-09-10 | — | |
| 10-Q | — | 2026-07-15 | 2026-06-30 | |
| 8-K | — | 2026-07-15 | — | |
| Investor Event Transcript | — | 2026-06-10 | 2026-06-30 | |
| 8-K | — | 2026-06-10 | — | |
| 8-K | — | 2026-05-13 | — | |
| 8-K | — | 2026-04-22 | — | |
| 10-Q | — | 2026-04-22 | 2026-03-31 | |
| DEFA14A | — | 2026-03-27 | — | |
| DEF 14A | — | 2026-03-27 | 2026-05-13 | |
| 8-K | — | 2026-03-10 | — | |
| 8-K | — | 2026-03-02 | — | |
| 8-K | — | 2026-02-26 | — | |
| 10-K | — | 2026-02-06 | 2025-12-31 | |
| 8-K | — | 2026-01-28 | — | |
| 8-K | — | 2025-12-10 | — | |
| 8-K | — | 2025-11-10 | — | |
| 8-K | — | 2025-10-21 | — | |
| 10-Q | — | 2025-10-21 | 2025-09-30 | |
| 8-K | — | 2025-09-15 | 2025-09-08 | |
| 8-K | — | 2025-09-04 | — | |
| 8-K | — | 2025-07-28 | — | |
| 8-K | — | 2025-07-17 | — | |
| 10-Q | — | 2025-07-17 | 2025-06-30 | |
| 8-K | — | 2025-05-28 | — | |
| 8-K | — | 2025-05-14 | — | |
| 8-K | — | 2025-04-22 | — | |
| 10-Q | — | 2025-04-22 | 2025-03-31 | |
| 8-K | — | 2025-04-17 | — | |
| DEFA14A | — | 2025-03-28 | — | |
| DEF 14A | — | 2025-03-28 | 2025-05-14 | |
| DEFA14A | — | 2025-03-28 | — | |
| 8-K | — | 2025-03-10 | — | |
| 10-K | — | 2025-02-20 | 2024-12-31 | |
| 8-K | — | 2025-01-23 | — | |
| 8-K | — | 2024-10-31 | 2024-10-22 | |
| 8-K | — | 2024-10-17 | — | |
| 10-Q | — | 2024-10-17 | 2024-09-30 | |
| 10-Q | — | 2024-07-17 | 2024-06-30 | |
| 8-K | — | 2024-07-17 | — | |
| 8-K | — | 2024-06-12 | — | |
| 8-K | — | 2024-05-30 | 2024-05-20 | |
| 8-K | — | 2024-05-15 | — | |
| DEFA14A | — | 2024-04-22 | — | |
| 10-Q | — | 2024-04-18 | 2024-03-31 | |
| 8-K | — | 2024-04-18 | — | |
| DEF 14A | — | 2024-03-29 | 2024-05-15 |
Showing 1–50 of 130 filings
Key facts
CIK
1156039
CUSIP
036752103
13F (30d)
429 filings
405 filers
Visit website
Investor relations